Norovirus Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Phase I Study to Determine the Optimal Human Challenge Dose for a Norovirus GII.4 Challenge Stock (CIN-1)
Condition: Gastroenteritis NorovirusInterventions: Other: Placebo; Biological: Norovirus GII.4 Challenge Pool CIN-1Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)Not yet recruiting - verified January 2015 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - January 8, 2015 Category: Research Source Type: clinical trials

Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults
Condition: NorovirusInterventions: Biological: Norovirus Bivalent VLP Vaccine; Drug: Placebo (Saline); Biological: Norovirus Bivalent VLP VaccineSponsor: TakedaNot yet recruiting - verified May 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2014 Category: Research Source Type: clinical trials

Safety and Immunogenicity of Norovirus Bivalent Virus-Like Particle Vaccine in Healthy Adults
Condition: NorovirusInterventions: Biological: Norovirus Bivalent VLP Vaccine; Drug: Placebo (Saline); Biological: Norovirus Bivalent VLP VaccineSponsor: TakedaRecruiting - verified July 2014 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - May 9, 2014 Category: Research Source Type: clinical trials